Læknablaðið

Volume

Læknablaðið - 01.04.1978, Page 68

Læknablaðið - 01.04.1978, Page 68
82 LÆKNABLAÐIÐ 72. Pell, S. & D'Alonzo, C.A. Acute myocardial infarction in a larpe industrial population. — Report of 6-year study of 1356 cases. JAMA 105, 831. 1963. 73. Peters, T.J. & de Deuve. Lysomes of t.he arterial wall. J. Exp. Med. 136: 117, 1972. 74. Pikkarainen, J. et al.: Serum cholesterol in Finnish twins. Amer. J. Hum. Genet. 18, 115. 1966. 75. Pyke, D.A. Arterial disease and diabetes í Clinical Diabetes (Oakley, W.E., Pyke, D.A. & Taylor, K.W.) [Blackwell Sci. Publ.] Ox- ford. 1968. 76. Rannsóknarstöð Hjartaverndar. Skýrsla AIII. Betalipoprotein, tótal kólesteról op brífflyser- íðar í venublóði ísl. karla á aldrinum 34—61 árs. 77. Recommendation from the findings by the RCGP oral contraception study on the morta- lity risks of oral cont.receptive users. Brit. Med. J. 2, 947. 1977. 78. Reid, D.D. et al.: Smokinp: and other risk factors for coronary heart-disease in British civil servants. Lancet 979-984. 1976. 79. Robertson, W.B. The International Atheros- clerosis Project, Path. Microbiol. 30:810. 1967. 80. Rose, G. Detection of hiph coronary risk. Postgrad. Med. J. 52, 452. 1976. 81. Rose, G. Smoking and cardiovascular disease. Amer. Heart J. 85, 838-840. 1973. 82. Rose, G. Familial pattern in ischaemic heart disease. Brit. J. prev. soc. Med. 18, 75. 1964. 83. Rose, G. et al.: Myocardial ischaemia, risk factors and deat.h from coronary heart dis- ease. Lancet 105. 1977. 84. Rosenman, R.H. et al.: Multivariate prediction of coronary heart disease during 8.5 year follow up in the Western Collaborative Group Study. Amer. J. Cardiol. 37:903. 1976. 85. Ross, R. & Glomset, J.A. The pathogenesis of atherosclerosis. New Engl. J. Med. 295:369- 377, 420-425. 1976. 86. Ross, R. & Harker, L. Hyperlipidemia and atherosclerosis; Chronic hyperlipemia iniates and maintains lesions by endot.helial cell des- quamation and lipid accumulation. Science 193:1094-1100. 1976. 87 Royal College of General Practitioners* Oral Contraception Study. Mortality among oral- contraceptive users. Lancet 727. 1977. 88. Schievelbein. H. & Eberhardt, R.J. natn. Cancer Inst. 48, 1785. 1972. 89. Schaefer, L.E. et al.: Heredity, environment and serum cholesterol. Circulation 17, 537. 1958. 90. Shaper, A.G. Primary aiyi secondary pre- vention trials in coronary heart disease. Post- grad. Med. J. 52. 464. 1976. 91. Sigurðsson G. et al.: Conversion of very low density lipoprotein to low density lipoprotein. J. Clin. Invest 56. 1481. 1975. 92. Sigurðsson, G. et al.: Quantification of the hepatic cont.ribution to the catabolism of high density aDolipoprotein in the rat. Circulation (Suppl. III), 3, 1977. 93. Sigurjónsson, J. Occupational variations in mortality from ischaemic heart. disease. J. Am. Geriatr. Soc. 19, 34. 1971. 94. Siperstein, M.D. The glucose tolerance test: nitfall in t.he diagnosis of diabetes mellitus. T Controversy in Medicine II. (Ingelfinger, F.J. cd.) TSaundersl 1972. 95. Slack, J. Genetic differences in liability to ntherosclerotic heart disease. J. Roy. Coll. Phycns. London. 8. 115. 1974. 96. Slack, J. & Evans, K.A. The increased risk of death from ischaemic heart disease in first degree relatives of 121 men and 96 women wit.h ischaemic heart disease. J. Med. Genet. 3, 239. 1966. 97. Smith. E.B. The Relationship Between Plasma and Tissue Lipids in Human Atherosclerosis. Adv. Lipid Res. 12, 49. 1974. 98. Smith, E.B. & Slater, R.S. Relationship between low-densit.y lipoprotein in aortic in- tima and serum-lipid levels. Lancet, i, 463. 1972. 99. Smith, E.B. & Smith, R.H. Early Changes in Aortic Intima. Atherosclerosis Reviews, Vol. I, p.p. 119-134. (Ed. R. Paoletti & A.M. Gotts) [Raven Press] N.Y. 1976. 100. Stamler, J. Bull. N.Y. Acad. Med. 44, 1476. 1968. 101. Stamler, J. et al.: Risk factors: Their role in the etiology and pathogenesis of the athero- sclerotic diseases. Pathogenesis of athero sclerosis (eds. Wissler, R.W. & Geer, J.C.) [Williams & Wilkins] Baltimore, Maryland. 1972. 102. Stern, M.P. et al.: Cardiovascular risk and use of estrogens or estrogenprogestagen combi- nation. JAMA 235, 811. 1976. 103. Stokes, T. & Wynn, V. serum lipids in women on oral contraceptives. Lancet 677. 1971. 104. Taylor, H.L. Occupational factors in the study of coronary heart disease and physical acti- vit.y. Canad. Med. Ass. J. 96, 825. 1967. 105. Taylor, H.L. et al.: Five year follow-up of employees of selected U.S. railroad companies. í Coronary Heart. Disease in Seven Countries. (Keyes A. Ed.) Circulation. Apríl 1970. 106. Ten-year follow-up report on Birmingham Diabetes Survey of 1961. Brit. Med. J. 2, 35. 1976. 107. Trial of Clofibrate in the treatment of ischa- emic heart. disease. Five year study by a group of physicians of the Newcastle upon Tyne Region. Brit. Med. J. 4, 767. 1971. 108. The University Group Diabetes Program: A study of the effect of hypoglycemic agents on vascular complications in patients with adult onset diabetes. Part II: Mortality results. Diabetes 19 (Suppl. 2) 747-830. 1970. Part V: Evaluation of Phenformin t.herapy. Diabetes 24 (Suppl 1) :65-184. 1975. 109: Vesselinovitch, D. et al.: Reversal of advanced atherosclerosis in rhesus monkeys. Part 1: Light microscopic studies. Atherosclerosis, 23: 155. 1976. 110. Vessey, M.P. et al.: Mortality among women participat.ing in the Oxford family planning association contraceptive study. Lancet 731. 1977. 111. Veterans Administration Cooperative Study; Effects of t.reatment on morbidity in hyper- tension. JAMA 202, 116-122. 1967. 112. Veterans Administration Cooperative Study; Effects of treatment on morbidity in hyper- t^nsion II. JAMA 213, 1143-1152. 1970. 113. Walker, W.J. Changing United States Life- Style: and declining vascular mortality; cause or coincidense. New Engl. J. Med. 297, 163. 1977. 114. Walton, K.W. Identification of Lipoproteins involved in Human Atherosclerosis. Athero- sclerosis III (ed. G. Schet.tler & A. Weigel) [Springer] Berlin. 1974. 115. Wilhelmsson, C. et al.: Smoking and myo- cardial infarction. Lancet i, 415. 1975. 116. Zilversmit, D.B. Role of triglyceride — rich lipoproteins in atherogenesis. Ann. N.Y. Acad. Sci. 275, 138. 1976.
Page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
Page 10
Page 11
Page 12
Page 13
Page 14
Page 15
Page 16
Page 17
Page 18
Page 19
Page 20
Page 21
Page 22
Page 23
Page 24
Page 25
Page 26
Page 27
Page 28
Page 29
Page 30
Page 31
Page 32
Page 33
Page 34
Page 35
Page 36
Page 37
Page 38
Page 39
Page 40
Page 41
Page 42
Page 43
Page 44
Page 45
Page 46
Page 47
Page 48
Page 49
Page 50
Page 51
Page 52
Page 53
Page 54
Page 55
Page 56
Page 57
Page 58
Page 59
Page 60
Page 61
Page 62
Page 63
Page 64
Page 65
Page 66
Page 67
Page 68
Page 69
Page 70
Page 71
Page 72
Page 73
Page 74
Page 75
Page 76
Page 77
Page 78
Page 79
Page 80
Page 81
Page 82
Page 83
Page 84
Page 85
Page 86
Page 87
Page 88
Page 89
Page 90
Page 91
Page 92
Page 93
Page 94
Page 95
Page 96
Page 97
Page 98
Page 99
Page 100
Page 101
Page 102
Page 103
Page 104
Page 105
Page 106
Page 107
Page 108
Page 109
Page 110

x

Læknablaðið

Direct Links

If you want to link to this newspaper/magazine, please use these links:

Link to this newspaper/magazine: Læknablaðið
https://timarit.is/publication/986

Link to this issue:

Link to this page:

Link to this article:

Please do not link directly to images or PDFs on Timarit.is as such URLs may change without warning. Please use the URLs provided above for linking to the website.